Back | Next |
home / stock / xbio / xbio message board
Subject | By | Source | When |
---|---|---|---|
We need green tomorrow | masterofdisaster | investorshub | 08/17/2021 12:04:35 AM |
2.7 million FTDs in late July | masterofdisaster | investorshub | 08/17/2021 12:03:47 AM |
Any thoughts on the S3 filing? This may | masterofdisaster | investorshub | 08/16/2021 12:25:42 PM |
Just slapped it for 1200 more. Enjoy the ride | masterofdisaster | investorshub | 08/13/2021 3:10:13 PM |
Time to load up cheapies $$$$ | INFINITI | investorshub | 08/13/2021 1:40:44 PM |
whytestocks: $XBIO News Article - Xenetic Biosciences, Inc. Reports Second Quarter 2021 Financial Re | whytestocks | investorshangout | 08/13/2021 12:15:48 PM |
Cmon slap that ask $$$$ | INFINITI | investorshub | 08/12/2021 7:35:07 PM |
$XBIO - Major Buy Alert | Jake L | investorshub | 08/12/2021 5:19:08 PM |
J L: XBIO - Major Buy Alert https://youtu.be/rfyHl8ltqqA | J L | investorshangout | 08/12/2021 5:09:42 PM |
Yes just getting started | masterofdisaster | investorshub | 08/12/2021 3:05:32 PM |
Going to run load up$$$$ | INFINITI | investorshub | 08/12/2021 1:57:41 PM |
More room to run on this? | jxphilli | investorshub | 08/12/2021 1:50:34 PM |
Cant wait $$$& | INFINITI | investorshub | 08/12/2021 1:33:31 PM |
Yes it does. On the SHO list with | masterofdisaster | investorshub | 08/12/2021 12:48:21 PM |
Got in looks like its ready to burst $$$ | INFINITI | investorshub | 08/12/2021 12:14:29 PM |
How high can she go | INFINITI | investorshub | 08/12/2021 12:02:15 PM |
Buy the dip. This is a low volume | masterofdisaster | investorshub | 08/11/2021 6:49:05 PM |
Strong close | masterofdisaster | investorshub | 08/10/2021 8:00:37 PM |
Bigger move coming | masterofdisaster | investorshub | 08/10/2021 5:11:16 PM |
This is just the beginning. HODL | masterofdisaster | investorshub | 08/10/2021 4:14:23 PM |
News, Short Squeeze, Breakout and More Instantly...
Xenetic Biosciences Inc. Company Name:
XBIO Stock Symbol:
NASDAQ Market:
Xenetic Biosciences Inc. Website:
Ongoing preclinical studies with multiple data readouts expected throughout remainder of 2024 Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Ended the qu...
Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Ended the year with $9.0 million of cash to fund operations FRAMINGHAM, MA / ACCESSWIRE / March 22, 2024 /...
- Company building growing body of preclinical data to guide pathway to first in human trial for DNase-based oncology platform FRAMINGHAM, MA / ACCESSWIRE / January 17, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advan...